BioXcel Therapeutics, Inc.

DB:BX2 Stock Report

Market Cap: €19.2m

BioXcel Therapeutics, Inc. Company Information

BioXcel Therapeutics, Inc.'s employee growth, exchange listings and data sources

Key Information

  • Name: BioXcel Therapeutics, Inc.
  • Ticker: BX2
  • Exchange: DB
  • Founded: 2017
  • Industry: Biotechnology
  • Sector: Pharmaceuticals & Biotech
  • Market Cap: US$20.092m
  • Listing Market Cap: US$19.178m
  • Shares Outstanding: 42.75m
  • Website: https://www.bioxceltherapeutics.com

Number of Employees

Location

  • BioXcel Therapeutics, Inc.
  • 555 Long Wharf Drive
  • 12th Floor
  • New Haven
  • Connecticut
  • 06511
  • United States

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
BTAINasdaqCM (Nasdaq Capital Market)YesCommon StockUSUSDMar 2018
BX2DB (Deutsche Boerse AG)YesCommon StockDEEURMar 2018

Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2024/11/26 23:28
End of Day Share Price 2024/11/26 00:00
Earnings2024/09/30
Annual Earnings2023/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.